Carcinoma, Islet Cell - 25 Studies Found
Completed |
: Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy :
|
Withdrawn |
: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy :
|
Recruiting |
: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas :
|
Completed |
: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma :
|
Completed |
: Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors :
|
Recruiting |
: Clinical Evaluation of i-STAT Analyzer :
|
Active, not recruiting |
: Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery :
|
Active, not recruiting |
: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors :
|
Withdrawn |
: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors :
|
Recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors :
|